• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Tax和M1肽/HLA - A2特异性Fab片段及T细胞受体识别肽/HLA - A2复合物上不同的结构特征。

Tax and M1 peptide/HLA-A2-specific Fabs and T cell receptors recognize nonidentical structural features on peptide/HLA-A2 complexes.

作者信息

Biddison William E, Turner Richard V, Gagnon Susan J, Lev Avital, Cohen Cyril J, Reiter Yoram

机构信息

Molecular Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

J Immunol. 2003 Sep 15;171(6):3064-74. doi: 10.4049/jimmunol.171.6.3064.

DOI:10.4049/jimmunol.171.6.3064
PMID:12960332
Abstract

Both TCRs and Ab molecules are capable of MHC-restricted recognition of peptide/MHC complexes. However, such MHC restriction is the predominant mode of recognition by T cells, but is extremely rare for B cells. The present study asks whether the dichotomy in Ag recognition modes of T and B cells could be due to fundamental differences in the methods by which TCRs and Abs recognize peptide/MHC complexes. We have compared MHC and peptide recognition by panels of CTL lines specific for the Tax and M1 peptides presented by HLA-A2 plus Tax and M1 peptide/HLA-A2-specific human Fabs that were selected from a naive phage display library. Collectively, the results indicate both striking similarities and important differences between Fab and TCR recognition of MHC and peptide components of the Tax and M1/HLA-A2 complexes. These findings suggest that these two classes of immunoreceptors have solved the problem of specific recognition of peptide/MHC complexes by nonidentical mechanisms. This conclusion is important in part because it indicates that Ab engineering approaches could produce second-generation Ab molecules that more closely mimic TCR fine specificity. Such efforts may produce more efficacious diagnostic and therapeutic agents.

摘要

T细胞受体(TCRs)和抗体(Ab)分子都能够对肽/MHC复合物进行MHC限制识别。然而,这种MHC限制是T细胞识别的主要模式,但对B细胞来说极为罕见。本研究探讨T细胞和B细胞在抗原识别模式上的二分法是否可能源于TCRs和Abs识别肽/MHC复合物方式的根本差异。我们比较了针对由HLA - A2递呈的Tax和M1肽的CTL系组以及从天然噬菌体展示文库中筛选出的Tax和M1肽/HLA - A2特异性人Fab对MHC和肽的识别。总体而言,结果表明Fab和TCR对Tax和M1/HLA - A2复合物的MHC和肽成分的识别既有显著相似性也有重要差异。这些发现表明这两类免疫受体通过不同机制解决了肽/MHC复合物的特异性识别问题。这一结论部分很重要,因为它表明抗体工程方法可以产生更紧密模拟TCR精细特异性的第二代抗体分子。此类努力可能会产生更有效的诊断和治疗药物。

相似文献

1
Tax and M1 peptide/HLA-A2-specific Fabs and T cell receptors recognize nonidentical structural features on peptide/HLA-A2 complexes.Tax和M1肽/HLA - A2特异性Fab片段及T细胞受体识别肽/HLA - A2复合物上不同的结构特征。
J Immunol. 2003 Sep 15;171(6):3064-74. doi: 10.4049/jimmunol.171.6.3064.
2
Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies.人类MHC I类抗原呈递的直接表型分析:使用肽特异性、MHC限制性人类重组抗体对人类病毒表位进行可视化、定量分析和原位检测。
J Immunol. 2003 Apr 15;170(8):4349-61. doi: 10.4049/jimmunol.170.8.4349.
3
MHC allele-specific molecular features determine peptide/HLA-A2 conformations that are recognized by HLA-A2-restricted T cell receptors.MHC等位基因特异性分子特征决定了被HLA - A2限制性T细胞受体识别的肽/HLA - A2构象。
J Immunol. 2002 Sep 15;169(6):3146-54. doi: 10.4049/jimmunol.169.6.3146.
4
Extensive T cell receptor cross-reactivity on structurally diverse haptenated peptides presented by HLA-A2.HLA - A2 所呈递的结构多样的半抗原化肽段上广泛的 T 细胞受体交叉反应性。
Mol Immunol. 2006 Feb;43(4):346-56. doi: 10.1016/j.molimm.2005.02.011.
5
MHC recognition by hapten-specific HLA-A2-restricted CD8+ CTL.半抗原特异性HLA - A2限制性CD8 + 细胞毒性T淋巴细胞对MHC的识别
J Immunol. 2003 Sep 1;171(5):2233-41. doi: 10.4049/jimmunol.171.5.2233.
6
Peptide recognition by two HLA-A2/Tax11-19-specific T cell clones in relationship to their MHC/peptide/TCR crystal structures.两个HLA - A2/Tax11 - 19特异性T细胞克隆对肽的识别及其与MHC/肽/TCR晶体结构的关系
J Immunol. 1999 May 1;162(9):5389-97.
7
Structural basis for clonal diversity of the human T-cell response to a dominant influenza virus epitope.人类T细胞对主要流感病毒表位应答的克隆多样性的结构基础
J Biol Chem. 2017 Nov 10;292(45):18618-18627. doi: 10.1074/jbc.M117.810382. Epub 2017 Sep 20.
8
Modification of a tumor-derived peptide at an HLA-A2 anchor residue can alter the conformation of the MHC-peptide complex: probing with TCR-like recombinant antibodies.在HLA - A2锚定残基处对肿瘤衍生肽进行修饰可改变MHC - 肽复合物的构象:用类TCR重组抗体进行探测。
J Immunol. 2002 Oct 15;169(8):4399-407. doi: 10.4049/jimmunol.169.8.4399.
9
Identification of a crucial energetic footprint on the alpha1 helix of human histocompatibility leukocyte antigen (HLA)-A2 that provides functional interactions for recognition by tax peptide/HLA-A2-specific T cell receptors.在人类组织相容性白细胞抗原(HLA)-A2的α1螺旋上鉴定出一个关键的能量足迹,该足迹为tax肽/HLA-A2特异性T细胞受体的识别提供功能相互作用。
J Exp Med. 2001 Mar 5;193(5):551-62. doi: 10.1084/jem.193.5.551.
10
Impact of antigen presentation on TCR modulation and cytokine release: implications for detection and sorting of antigen-specific CD8+ T cells using HLA-A2 wild-type or HLA-A2 mutant tetrameric complexes.抗原呈递对TCR调节和细胞因子释放的影响:使用HLA - A2野生型或HLA - A2突变体四聚体复合物检测和分选抗原特异性CD8 + T细胞的意义。
J Immunol. 2002 Mar 15;168(6):2766-72. doi: 10.4049/jimmunol.168.6.2766.

引用本文的文献

1
DNA sensing via the cGAS/STING pathway activates the immunoproteasome and adaptive T-cell immunity.通过 cGAS/STING 途径感知 DNA 可激活免疫蛋白酶体和适应性 T 细胞免疫。
EMBO J. 2023 Apr 17;42(8):e110597. doi: 10.15252/embj.2022110597. Epub 2023 Mar 13.
2
T-cell receptor mimic (TCRm) antibody therapeutics against intracellular proteins.针对细胞内蛋白的T细胞受体模拟(TCRm)抗体疗法。
Antib Ther. 2019 Jan 21;2(1):22-32. doi: 10.1093/abt/tbz001. eCollection 2019 Jan.
3
Engineering soluble T-cell receptors for therapy.工程化可溶性 T 细胞受体治疗。
FEBS J. 2021 Nov;288(21):6159-6173. doi: 10.1111/febs.15780. Epub 2021 Mar 10.
4
Specificity of bispecific T cell receptors and antibodies targeting peptide-HLA.双特异性 T 细胞受体和针对肽-HLA 的抗体的特异性。
J Clin Invest. 2020 May 1;130(5):2673-2688. doi: 10.1172/JCI130562.
5
Opportunities and Challenges for Antibodies against Intracellular Antigens.针对细胞内抗原的抗体的机遇与挑战。
Theranostics. 2019 Oct 15;9(25):7792-7806. doi: 10.7150/thno.35486. eCollection 2019.
6
Targeting the MHC Ligandome by Use of TCR-Like Antibodies.利用类TCR抗体靶向主要组织相容性复合体配体组
Antibodies (Basel). 2019 May 9;8(2):32. doi: 10.3390/antib8020032.
7
TCR-like antibodies in cancer immunotherapy.T 细胞受体样抗体在癌症免疫治疗中的应用。
J Hematol Oncol. 2019 Sep 14;12(1):99. doi: 10.1186/s13045-019-0788-4.
8
TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies.靶向 LMP2A 的 TCR-模拟双特异性抗体对 EBV 恶性肿瘤显示出强大的活性。
JCI Insight. 2018 Feb 22;3(4). doi: 10.1172/jci.insight.97805.
9
Therapeutic Antibodies against Intracellular Tumor Antigens.针对细胞内肿瘤抗原的治疗性抗体。
Front Immunol. 2017 Aug 18;8:1001. doi: 10.3389/fimmu.2017.01001. eCollection 2017.
10
Targeting Epstein-Barr virus-transformed B lymphoblastoid cells using antibodies with T-cell receptor-like specificities.使用具有T细胞受体样特异性的抗体靶向爱泼斯坦-巴尔病毒转化的B淋巴母细胞。
Blood. 2016 Sep 8;128(10):1396-407. doi: 10.1182/blood-2016-03-707836. Epub 2016 Jun 23.